Literature DB >> 23722670

miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1.

Haosha Tang1, Liangqing Yao, Xiang Tao, Yi Yu, Mo Chen, Rong Zhang, Congjian Xu.   

Abstract

microRNAs (miRNAs) are important regulators of gene expression during tumorigenesis. The downregulation of microRNA-9 (miR-9) has been reported in ovarian serous carcinoma (OSC), indicating a role for miR-9 in this type of cancer. In this study, we investigated the biological significance of miR-9 in OSC in vitro. Using 3 OSC cell lines, SKOV3, CAOV3 and OVCAR3, which underexpresss miR-9, we demonstrate that the exogenous miR-9 transfection inhibits OSC cell proliferation, migration and invasion. In addition, we demonstrate that the focal adhesion protein, talin 1 (TLN1), whose expression has been associated with OSC development and progression to metastasis, is a direct target of miR-9. TLN1 knockdown mimicked the effects of miR-9 overexpression. Moreover, the activation of the TLN1-modulated FAK/AKT pathway was inhibited by the increased miR-9 levels. These results suggest that miR-9 plays a role as a tumor suppressor in OSC by suppressing TLN1 expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23722670     DOI: 10.3892/ijmm.2013.1400

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  31 in total

1.  Increased expression of microRNA-9 predicts an unfavorable prognosis in human glioma.

Authors:  Zhenyu Wu; Liang Wang; Gang Li; Hui Liu; Feiyan Fan; Zhaobo Li; Yunqing Li; Guodong Gao
Journal:  Mol Cell Biochem       Date:  2013-12       Impact factor: 3.396

2.  miR-9-3p inhibits glioma cell proliferation and apoptosis by directly targeting FOXG1.

Authors:  Jianwen Zhen; Hengxun Zhang; Hongzhi Dong; Xiaopeng Tong
Journal:  Oncol Lett       Date:  2020-06-11       Impact factor: 2.967

3.  Downregulation of Talin-1 is associated with the increased expression of miR-182-5p and miR-9-5p in coronary artery disease.

Authors:  Akram Gholipour; Farshad Shakerian; Ali Zahedmehr; Shiva Irani; Seyed Javad Mowla; Mahshid Malakootian
Journal:  J Clin Lab Anal       Date:  2022-02-14       Impact factor: 2.352

4.  MicroRNA-9 is a ponderable index for the prognosis of human hepatocellular carcinoma.

Authors:  Jingchang Sun; Kunpeng Fang; Hang Shen; Yeben Qian
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  Synergistic Beneficial Effect of Docosahexaenoic Acid (DHA) and Docetaxel on the Expression Level of Matrix Metalloproteinase-2 (MMP-2) and MicroRNA-106b in Gastric Cancer.

Authors:  Najibeh Shekari; Mahsa Javadian; Mottahareh Ghasemi; Behzad Baradaran; Masoud Darabi; Tohid Kazemi
Journal:  J Gastrointest Cancer       Date:  2020-03

6.  MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS.

Authors:  Xin Fu; Yanfen Cui; Shaobin Yang; Yue Xu; Zicheng Zhang
Journal:  Tumour Biol       Date:  2015-12-02

7.  miR-761 inhibits tumor progression by targeting MSI1 in ovarian carcinoma.

Authors:  Can Shi; Zhenyu Zhang
Journal:  Tumour Biol       Date:  2015-11-12

Review 8.  Epigenetic regulation of microRNAs in gastric cancer.

Authors:  Jiaojiao Ma; Liu Hong; Zheng Chen; Yongzhan Nie; Daiming Fan
Journal:  Dig Dis Sci       Date:  2013-11-19       Impact factor: 3.199

9.  Upregulated Talin1 synergistically boosts β-estradiol-induced proliferation and pro-angiogenesis of eutopic and ectopic endometrial stromal cells in adenomyosis.

Authors:  Yi-Yi Wang; Hua Duan; Sha Wang; Yong-Jun Quan; Jun-Hua Huang; Zheng-Chen Guo
Journal:  Reprod Biol Endocrinol       Date:  2021-05-14       Impact factor: 5.211

10.  High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma.

Authors:  Ya-Fei Xu; Xian-Yue Ren; Ying-Qin Li; Qing-Mei He; Xin-Ran Tang; Ying Sun; Jian-Yong Shao; Wei-Hua Jia; Tie-Bang Kang; Mu-Sheng Zeng; Na Liu; Jun Ma
Journal:  BMC Cancer       Date:  2015-04-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.